Healthcare >> CEO Interviews >> July 8, 2002
LAWRENCE A. KENYON joined NeoPharm, Inc., September 2000 as Chief
Financial Officer. From October 1999 until September 2000 Mr. Kenyon was
Senior Vice President of the Gabelli Mathers Fund, a regulated
investment company. Prior to that, Mr. Kenyon held a variety of
positions with Mathers and Company, Inc., an investment management firm,
most recently serving as the Chief Financial officer for both Mathers
and Company, Inc., and Mathers Fund, Inc., a regulated investment
company. Mr. Kenyon is a Certified Public Accountant and received his
BBA in Accounting from the University of Wisconsin-Whitewater in 1987. Profile
Mr. Kenyon: NeoPharm is a biopharmaceutical company focused on the
research, development and commercialization of drugs for the treatment
of cancer.
